Alcidion Group Ltd Cash Flow Conversion Efficiency
Alcidion Group Ltd cash flow conversion efficiency. Based on the latest financial reports, Alcidion Group Ltd (ALC) has a cash flow conversion efficiency ratio of 0.113x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$9.88 Million ≈ $6.99 Million USD) by net assets (AU$87.80 Million ≈ $62.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Alcidion Group Ltd (2011–2025)
Cash flow conversion efficiency of Alcidion Group Ltd from 2011 to 2025. This chart illustrates how Alcidion Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ALC share price today for real-time trading data and today's change.
Alcidion Group Ltd Cash Flow Conversion Ratio Explained
Alcidion Group Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Alcidion Group Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alcidion Group Ltd ranked by their cash flow conversion efficiency. Also see market value of Alcidion Group Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Union Bankshares Inc
NASDAQ:UNB
|
0.125x |
|
FCR Immobilien AG
XETRA:FC9
|
0.076x |
|
We & Win Development Co Ltd
TW:2537
|
0.033x |
|
Titomic Ltd
AU:TTT
|
-0.311x |
|
Ctek AB
ST:CTEK
|
0.182x |
|
Tiong Nam Logistics Holdings Bhd
KLSE:8397
|
0.045x |
|
Lemonsoft Oyj
HE:LEMON
|
0.093x |
|
Top Union Electronics
TWO:6266
|
0.064x |
Annual Cash Flow Conversion Efficiency for Alcidion Group Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Alcidion Group Ltd from 2011 to 2025. Review free cash flow generation of Alcidion Group Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$87.80 Million ≈ $62.12 Million |
AU$5.76 Million ≈ $4.08 Million |
0.066x | +180.05% |
| 2024-06-30 | AU$86.94 Million ≈ $61.52 Million |
AU$-7.13 Million ≈ $-5.04 Million |
-0.082x | -4474.82% |
| 2023-06-30 | AU$90.17 Million ≈ $63.80 Million |
AU$169.00K ≈ $119.58K |
0.002x | -82.32% |
| 2022-06-30 | AU$93.95 Million ≈ $66.48 Million |
AU$996.00K ≈ $704.73K |
0.011x | -68.97% |
| 2021-06-30 | AU$45.22 Million ≈ $32.00 Million |
AU$1.54 Million ≈ $1.09 Million |
0.034x | +150.37% |
| 2020-06-30 | AU$29.74 Million ≈ $21.04 Million |
AU$-2.02 Million ≈ $-1.43 Million |
-0.068x | -145.12% |
| 2019-06-30 | AU$13.24 Million ≈ $9.37 Million |
AU$1.99 Million ≈ $1.41 Million |
0.150x | +127.45% |
| 2018-06-30 | AU$3.33 Million ≈ $2.36 Million |
AU$-1.83 Million ≈ $-1.29 Million |
-0.548x | -471.68% |
| 2017-06-30 | AU$5.42 Million ≈ $3.84 Million |
AU$-519.42K ≈ $-367.52K |
-0.096x | +76.05% |
| 2016-06-30 | AU$6.57 Million ≈ $4.65 Million |
AU$-2.63 Million ≈ $-1.86 Million |
-0.400x | -427.59% |
| 2015-06-30 | AU$3.75 Million ≈ $2.65 Million |
AU$-284.12K ≈ $-201.04K |
-0.076x | -41.84% |
| 2014-06-30 | AU$4.03 Million ≈ $2.85 Million |
AU$-215.19K ≈ $-152.26K |
-0.053x | -31.59% |
| 2013-06-30 | AU$4.18 Million ≈ $2.95 Million |
AU$-169.57K ≈ $-119.98K |
-0.041x | +96.03% |
| 2012-06-30 | AU$2.53 Million ≈ $1.79 Million |
AU$-2.58 Million ≈ $-1.83 Million |
-1.022x | -1078.04% |
| 2011-06-30 | AU$5.72 Million ≈ $4.04 Million |
AU$-495.97K ≈ $-350.93K |
-0.087x | -- |
About Alcidion Group Ltd
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. It offers Miya Precision, a fast healthcare interoperability resource (FHIR)-events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), an… Read more